L. Carulli et al., Regulation of ob gene expression: Evidence for epinephrine-induced suppression in human obesity, J CLIN END, 84(9), 1999, pp. 3309-3312
Leptin acts as satiety factor and increases energy expenditure. Studies con
ducted on animals and in vitro on adipocytes culture have shown that infusi
on of catecholamines leads to a significant reduction of ob gene expression
; it appears of interest to evaluate the in vivo effects of adrenergic acti
vation on the expression of the ob gene in humans.
We studied ob gene expression in adipose tissue samples from 13 obese subje
cts before and after epinephrine (25 ng/min.kg ideal body weight for 3 h) a
nd 6 obese patients during saline infusion. Hormonal infusion led to a sign
ificant increase in epinephrine plasma levels (from 27 +/- 4 to 339 +/- 75
pg/mL; P < 0.001), plasma free fatty acids (from 0.73 +/- 0.05 to 0.98 +/-
0.07; P < 0.05), heart rate (13.5 +/- 3.1 beats/min; F = 2.9; P < 0.03), an
d systolic blood pressure (F = 2.7; P < 0.05), whereas diastolic blood pres
sure did not show significant variation. Plasma leptin levels decreased by
the end of the infusion (from 63 +/- 13 to 49 +/-. 11 ng/mL; P < 0.05), and
ob messenger ribonucleic acid levels were significantly reduced (decrease
amounting to 47 +/- 5% of basal values). Our study shows that adrenergic ac
tivation contributes to regulate ob messenger ribonucleic acid levels in hu
mans. The interaction between epinephrine and leptin may operate during met
abolic and psychological stress to regulate energy expenditure and food int
ake.